Dudediligence.

Apyx Medical Corporation

APYXNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$11.5MSep ’24$14.2MDec ’24$9.4MMar ’25$11.4MJun ’25$12.9MSep ’25$19.2MDec ’25$12.5MMar ’26$13.9MJun ’26
Net income, by quarter
−$4.7MSep ’24−$4.6MDec ’24−$4.2MMar ’25−$3.8MJun ’25−$2.0MSep ’25−$1.3MDec ’25−$2.1MMar ’26−$3.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$48.5M$44.5M$52.3M$48.1M$52.8M
Gross profit$33.6M$29.1M$33.8M$29.4M$33.0M
Operating income−$14.4M−$23.6M−$17.3M−$18.8M−$6.4M
Net income−$15.2M−$23.2M−$18.7M−$23.5M−$11.2M
Operating cash flow−$10.4M−$20.3M−$5.2M−$18.0M−$8.0M
Free cash flow−$11.2M−$21.3M−$5.8M−$18.8M−$9.1M
Cash$30.9M$10.2M$43.7M$31.7M$31.7M
Debtnone on file$0.00$33.2M$33.9M$34.8M
Shares outstanding34.4M34.6M34.6M37.8M41.8M